The Promise of Chemotherapy-Free Strategies in Advanced Driver-Negative NSCLC: A Systematic Review and Network Meta-Analysis of Antiangiogenic Combination Therapies. [PDF]
ABSTRACT Background Antiangiogenic combination therapy—antiangiogenic agents combined with immune checkpoint inhibitors and/or chemotherapy—has become an important treatment strategy for advanced driver‐negative non‐small cell lung cancer (NSCLC). We conducted a network meta‐analysis to compare efficacy and safety and identify optimal antiangiogenic ...
Li Z +8 more
europepmc +2 more sources
Endostatin-expressing endometrial mesenchymal stem cells inhibit angiogenesis in endometriosis through the miRNA-21-5p/TIMP3/PI3K/Akt/mTOR pathway. [PDF]
Cheng Y +9 more
europepmc +3 more sources
Efficacy and safety of Rh-endostatin in the treatment of radiation pneumonitis in non-small cell lung cancer. [PDF]
Chen G +11 more
europepmc +2 more sources
A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer. [PDF]
Gao C, Gao C, Yuan Q.
europepmc +2 more sources
The pathogenic spirochete Leptospira interrogans disseminates throughout its hosts via the bloodstream, then invades and colonizes a variety of host tissues.
Brian Stevenson +12 more
doaj +1 more source
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review [PDF]
Age-related macular degeneration (AMD) is a complex and multifactorial disease and a leading cause of irreversible blindness in the elderly population. The anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the management and ...
Finocchio L. +5 more
core +1 more source
Background: Impaired angiogenesis and formation of collateral vessels in skeletal and cardiac muscle, is a major complication of type 2 diabetes mellitus in ischemia. The aim of this study was to evaluate the changes in vascular endothelial grows factor (
Saeed Esmaeili +3 more
doaj +1 more source
Antiangiogenesis signals by endostatin [PDF]
ABSTRACT Endostatin is a potent endogenous angiogenesis inhibitor that induces regression of tumors in mice. Neither an extracellular receptor for endostatin nor intracellular signals that result in the regression of tumor vascular beds have been identified.
M, Shichiri, Y, Hirata
openaire +2 more sources
Einsatz kapillarelektrophoretischer Methoden für die Analytik von pharmazeutisch interessanten Substanzen in der biotechnologischen Produktion [PDF]
[no ...
Frerichs, Simona
core +2 more sources

